Cost analysis of intensive glycemic control in critically ill adult patients.
Zijlstra
Jan G
JG
Corstjens
Anouk M
AM
Tulleken
Jaap E
JE
Meertens
John H J M
JH
Ligtenberg
Jack J M
JJ
D001786:Blood Glucose / Q000378:metabolism*; D003362:Cost-Benefit Analysis; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy / Q000191:economics* / Q000401:mortality; D007328:Insulin / Q000191:economics* / Q000627:therapeutic use; D007362:Intensive Care Units / Q000191:economics*; D007902:Length of Stay / Q000191:economics*; D015996:Survival Rate; D016896:Treatment Outcome
D001786:Blood Glucose; D007328:Insulin